Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality
about
Current challenges in providing bariatric surgery in France: A nationwide study.Patient survival and risk of death after prostate cancer treatment in the Brazilian Unified Health System.Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapy.
P2860
Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality
@ast
Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality
@en
type
label
Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality
@ast
Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality
@en
prefLabel
Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality
@ast
Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality
@en
P2093
P2860
P356
P1433
P1476
Prostate cancer outcomes in France: treatments, adverse effects and two-year mortality
@en
P2093
Anne Fagot-Campagna
Bertrand Lukacs
Bertrand Millat
CNAMTS scientific board members
Eric Vicaut
Fred Paccaud
Jean-Christophe Thalabard
Michel Vidaud
Philippe Tuppin
Solène Samson
P2860
P2888
P356
10.1186/1471-2490-14-48
P577
2014-06-13T00:00:00Z
P5875
P6179
1050757848